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OBJECTIVE—Despite the beneﬁcial effects of resveratrol (RSV)
on cardiovascular disease and life span, its effects on type 2
diabetic nephropathy remain unknown. This study examined the
renoprotective effects of RSV in db/db mice, a model of type 2
diabetes.
RESEARCH DESIGN AND METHODS—db/db mice were treated
with RSV (0.3% mixed in chow) for 8 weeks. We measured urinary
albumin excretion (UAE), histological changes (including mesangial
expansion, ﬁbronectin accumulation, and macrophage inﬁltration),
oxidative stress markers (urinary excretion and mitochondrial
content of 8-hydroxy-2’-deoxyguanosine [8-OHdG], nitrotyrosine
expression), and manganese-superoxide dismutase (Mn-SOD)
activity together with its tyrosine-nitrated modiﬁcation and mi-
tochondrial biogenesis in the kidney. Blood glucose, glycated
hemoglobin, and plasma lipid proﬁles were also measured. The
phosphorylation of 59-AMP–activated kinase (AMPK) and expres-
sion of silent information regulator 1 (SIRT1) in the kidney were
assessed by immunoblotting.
RESULTS—RSV signiﬁcantly reduced UAE and attenuated renal
pathological changes in db/db mice. Mitochondrial oxidative
stress and biogenesis were enhanced in db/db mice; however,
Mn-SOD activity was reduced through increased tyrosine-nitrated
modiﬁcation. RSV ameliorated such alterations and partially im-
proved blood glucose, glycated hemoglobin, and abnormal lipid
proﬁle in db/db mice. Activation of AMPK was decreased in the
kidney of db/db mice compared with db/m mice. RSV neither
modiﬁed AMPK activation nor SIRT1 expression in the kidney.
CONCLUSIONS—RSV ameliorates renal injury and enhanced
mitochondrial biogenesis with Mn-SOD dysfunction in the kidney
of db/db mice, through improvement of oxidative stress via nor-
malization of Mn-SOD function and glucose-lipid metabolism.
RSV has antioxidative activities via AMPK/SIRT1-independent
pathway. Diabetes 60:634–643, 2011
R
esveratrol (RSV; 3,5,4’-trihydroxystilbene) is re-
ported to be beneﬁcial in cardiovascular dis-
eases (1) and renal diseases (2–4), including
ischemic/reperfusion injury (5). The beneﬁcial
effects are thought to be due to its antioxidative properties
because it is known as a robust scavenger of superoxide
(O
22), hydroxyl radicals, and peroxynitrite (6,7). Oxidative
stress has been implicated in the pathogenesis of diabetic
vascular complications, including nephropathy (8). The
mitochondria are recognized as one of the major sources
of reactive oxygen species (ROS) in diabetes (9), and they
can also be damaged by ROS. Manganese-superoxide dis-
mutase (Mn-SOD), which is an important antioxidative
enzyme and mainly regulates ROS metabolism in the mi-
tochondria, is one of the mitochondrial targets of ROS
such as peroxynitrite, and thus its activity might become
reduced with ROS exposure (10). Therefore, conditions
that lead to Mn-SOD dysfunction could increase ROS
production and hence induce tissue damage associated
with diabetic nephropathy. However, it remains unclear
whether mitochondrial oxidative stress associated with
Mn-SOD dysfunction contributes to diabetes-induced renal
injury, and whether RSV has any beneﬁcial effects on mi-
tochondrial status including oxidative stress and bio-
genesis in the kidney of type 2 diabetes.
Reduced mitochondrial biogenesis and function are found
in insulin-resistant metabolic tissues including skeletal mus-
cle, liver, and fat in association with the pathogenesis of type
2 diabetes (11). In addition to the scavenging of ROS, RSV
enhances mitochondrial biogenesis through the 59-AMP–
activated kinase (AMPK)/silent information regulator 1
(SIRT1) pathway in the muscle and liver, resulting in life
span extension or improvement of high-fat diet–induced
metabolic impairment such as obesity and insulin re-
sistance (12–14). On the other hand, mitochondrial bio-
genesis can be induced in tissues not only by increased
energy demands due to cold, exercise, and metabolic
changes such as those induced by caloric restriction (15),
but also by damage to mitochondria caused by oxidative
stress (16–18) and hereditary disorders (19). Oxidative
stress-induced mitochondrial biogenesis has also been
reported in various tissues and cells (16–18), including the
myocardium of an animal model of type 1 diabetes (20).
There is little information on whether mitochondrial sta-
tus including mitochondrial biogenesis is changed in the
kidney of type 2 diabetes, and if so, how it is regulated
and whether it is related to the pathogenesis of diabetic
nephropathy.
Thus, the aim of this study was to investigate the po-
tential effects of RSV on mitochondrial oxidative stress
associated with Mn-SOD dysfunction and mitochondrial
biogenesis in the kidney of db/db mice. The results of the
current study indicate that the enhanced mitochondrial
biogenesis with Mn-SOD dysfunction induced by tyrosine
nitration was observed in the diabetic kidney. Treatment
with RSV resulted in the amelioration of these functional
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ORIGINAL ARTICLEand histological abnormalities and mitochondrial biogenesis
in the diabetic kidney, possibly by the attenuation of oxi-
dative stress through scavenging of ROS, normalization
of Mn-SOD dysfunction in an AMPK/SIRT1-independent
mechanism, and partial improvement of glucose-lipid
metabolism.
RESEARCH DESIGN AND METHODS
Materials and antibodies. Details of the materials and antibodies used in the
current study are available in the Supplementary Data.
Animals. Male db/db mice and age-matched db/m mice were purchased from
Clea Japan (Tokyo, Japan). At 9 weeks of age, mice were divided into four
groups: db/m mice, db/db mice, db/m mice treated with RSV, and db/db mice
treated with RSV. RSV was mixed (0.3%) with chow and administered orally.
Body weight, blood glucose level, food consumption, and blood pressure were
measured every 2 weeks in all animals. The blood pressure of conscious mice
was measured at steady state by a programmable tail-cuff sphygmomanometer
(BP98-A; Softron, Tokyo, Japan). At 17 weeks of age, individual mice were
placed in metabolic cages for 24-h urine collection. The urine samples were
stored at 280°C until analysis. Mice were anesthetized by intraperitoneal in-
jection of pentobarbital sodium, and then the right kidneys were removed and
stored at –80°C for experiments as described below. After collection of blood
samples from the left cardiac ventricle, the left kidney was perfused with ice-
cold phosphate-buffered saline (PBS) and 10% neutral buffered formalin and
then removed. The Research Center for Animal Life Science of Kanazawa
Medical University approved all experiments.
Morphological analysis and immunohistochemistry. To assess the mesan-
gial expansion, thirty glomeruli, cut at the vascular pole, randomly selected from
each mouse were measured the periodic acid/Schiff (PAS)-positive material
in the mesangial area and glomerular tuft area by computer-assisted color
image analysis (Micro Analyzer; Japan Poladigital, Tokyo, Japan) as previously
described (21).
For semiquantitative evaluation of the ﬁbronectin, F4/80 and nitrotyrosine
scores, 20 randomly selected glomerulus or tubulointerstitial areas per mouse
were graded in a double-blind manner, as reported previously (21–23), with
minor modiﬁcations.
8-OHdG levels in mitochondrial DNA and quantiﬁcation of mitochondrial
DNA deletion mutation. The mitochondrialDNA (mtDNA) was extracted from
the kidney using the mtDNA Extractor CT kit. The 8-OHdG levels in DNase I-
digestedmtDNA weredeterminedbyELISAusing a kit (8-OHdG Check,Institute
for the Control of Aging, Shizuoka, Japan) (24). We determined. the deletion
mutation, D-17, as reported previously (23). The sequences of primers are listed
in Supplementary Table 1.
Detection of O
22 formation in renal isolated mitochondria. The mito-
chondria were isolated from the renal cortex of all groups of mice using the
mitochondria isolation kit, according to the manufacturer’s instructions.
O
22production from the mitochondria was measured by L-012 chemiluminescence
(CL) dye (25). Mitochondrial suspensions were diluted to a ﬁnal protein
concentration of 0.1 mg/mL in 0.2 mL of PBS buffer containing 100 mmol/L
L-012. O
22 from mitochondria was detected after stimulation with 4 mmol/L
succinate and 20 mg/mL antimycin A by L-012. The CL registered at intervals of
30 s over 5 min with a chemiluminometer, and the signal was expressed as
counts of CL/min/100 mg protein at 5 min. In ex vivo study, similar experi-
ments were performed in isolated mitochondria from the renal cortex of db/db
mice at various concentrations (10
23–100 mmol/L) of RSV or 100 U/mL SOD. In
addition, O
22 from the reaction of hypoxanthine and xanthine oxidase was
also measured. L-012 (100 mM) was incubated for 5 min in PBS buffer con-
taining 100 mmol/L diethylenetriamine pentaacetic acid (DTPA) and 1 mmol/L
hypoxanthine at room temperature, and then the basal (background) signal
was determined in a chemiluminometer at intervals of 30 s for 5 min. The CL
was counted after the addition of 10 mU/mL xanthine oxidase at various
concentrations of RSV (10
23–100 mmol/L) or 100 U/mL SOD at intervals of 30 s
over 5 min.
Mn-SOD activity. The whole kidney was homogenized in 2 mL of 50 mmol/L
Tris HCl buffer containing 0.1 mmol/L ethylenediaminetetraacetic acid (EDTA)
at pH 7.0. After centrifugation at 15,000g for 15 min, the supernatant was re-
moved and total protein concentration was measured using a protein assay kit.
The Mn-SOD activity was measured by inhibiting extracellular and cytosolic
Cu/Zn SOD activity with KCN (1 mmol/L) using an SOD assay kit (WST-1) (26).
One unit of SOD activity was deﬁned as the amount causing 50% inhibition of
the initial rate of reduction of WST-1 (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-
(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt), a highly water-soluble
tetrazolium salt. Mn-SOD activity was calculated in terms of protein content
(U/mg) and expressed as a fold increase relative to that found in db/m mice.
Immunoprecipitation and Western blot analysis. The whole kidney was
homogenized in ice-cold radioimmunoprecipitation assay (RIPA) buffer. Solu-
bilized protein (1 mg) was used for immunoprecipitation with rabbit polyclonal
anti–Mn-SOD antibody (10 mg/mL) using protein A-Sepharose, and then Western
blot analysis was performed with mouse monoclonal antinitrotyrosine antibody
(1:1000) or rabbit polyclonal anti–Mn-SOD antibody (1:1000). Samples of pro-
tein solutions from the kidney were used for Western blotting with antiphospho-
AMPKa (Thr172) antibody, anti-AMPKa (23A3) antibody (1:1000), or anti-SIRT1
antibody (1:1000).
Quantitative real-time PCR. Isolation of total RNA from kidney, and de-
termination of complementary DNA synthesis by reverse transcription and
quantitative real-time PCR were performed as described previously (23). PCR
primer sets are listed (Supplementary Table 1).
Cell culture. Murine proximal tubular cells (mProx) (derivative, patent
WO9927363, Japan, U.S., European Union), kindly provided by CMIC Co., were
cultured as described previously (27).
Retroviral infection. The pSUPERretro and pSUPERretro-SIRT1 RNA in-
terference vectors were kind gifts from Dr. L. Guarente (Massachusetts In-
stitute of Technology, Cambridge, MA). Human embryonic kidney 293T cells
were transfected with pSUPERretro or pSUPERretro-SIRT1 RNAi by using
Lipofectamine reagent. At 48 h after transfection, the media containing the
retroviruses were collected, centrifuged, and transferred to mProx treated by
TABLE 1
Effects of RSV treatment on body weight, kidney weight, blood pressure, blood glucose, glycated hemoglobin, and lipid proﬁles in the
four groups of mice. Glycated hemoglobin was measured using an ADAMS-HA8106 analyzer (ARKRAY, Kyoto, Japan). Serum insulin
levels and urinary albumin excretion were measured with ELISA kits. Triglycerides, total cholesterol, and nonesteriﬁed fatty acid
(NEFA) were measured using an L-type triglyceride H kit, cholesterol E-test kit, and NEFA C-test kit, respectively
db/m db/m+RSV db/db db/db+RSV
n 19 17 19 18
Body weight (g) 29.0 6 2.31 28.6 6 1.32 49.3 6 2.70† 48.7 6 1.92†
Right kidney weight (g) 0.196 6 0.021 0.187 6 0.012 0.233 6 0.012† 0.217 6 0.012‡§
Mean blood pressure (mmHg) 94.7 6 5.30 94.9 6 4.97 102.8 6 6.56† 100.5 6 5.18║
Fasting blood glucose (mg/dL) 92.75 6 4.18 90.63 6 5.76 314.63 6 50.72† 264.75 6 44.17 †¶
Fasting serum insulin (ng/mL) 2.81 6 1.54 2.88 6 0.65 8.21 6 3.59† 4.40 6 1.44 †,#
*Random-fed blood glucose (mg/dL) 121.4 6 28.50 117.6 6 29.36 503.4 6 64.80† 426.9 6 90.52 †,* *
Glycated hemoglobin (%) 3.66 6 0.36 3.73 6 0.31 8.7 6 1.08† 7.78 6 0.46 †, ††
Total cholesterol (mg/dL) 60.9 6 8.12 62.2 6 7.29 122.2 6 22.84† 124.0 6 22.03†
Triglyceride (mg/dL) 71.9 6 20.9 65.4 6 22.0 205.3 6 52.10†† 126.6 6 58.07‡‡
Free fatty acids (mEq/L) 0.48 6 0.128 0.48 6 0.114 1.165 6 0.275†† 0.954 6 0.196††
Urinary albumin excretion (mg/day) 44.56 6 21.62 34.74 6 20.37 382.99 6 159.02†† 189.00 6 67.87‡‡
Data are means 6 SD. *Random-fed blood glucose levels were measured at 9–10 A.M. †P , 0.001 vs. db/m, db/m+RSV. ‡P , 0.05 vs. db/m,
db/db.§ P , 0.001 vs. db/m+RSV. ║P , 0.05 vs. db/m, db/m+RSV. ¶P , 0.05 vs. db/db.# P , 0.01 vs. db/db.* * P , 0.001 vs. db/db. ††P , 0.001 vs.
others, db/db. ‡‡P , 0.01 vs. db/m, db/m+RSV.
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romycin (2.5 mg/mL) for several days as described previously (28).
Infection of adenoviral dominant negative-AMPK. Adenoviruses con-
taining green ﬂuorescent protein (Ad-GFP) or dominant-negative AMPK
(DN-AMPK) were added to subconﬂuent mProx at a concentration of 50 mul-
tiplicity of infection for 1 h at 37°C in serum-free Dulbecco’sm o d i ﬁed Eagle’s
medium (29).
Detection of ROS in mProx. To determine the effect of RSV on oxidative
stress in mProx, cells were incubated with RSV (10 mmol/L) for 180 min at 37°C
before exposure to H2O2 (10 mmol/L). After incubation, the levels of intracellular
ROS were measured with the ﬂuoroprobe 2.7-dichlorodihydroﬂuorescein diac-
etate. The intracellular ROS was evaluated as the ﬂuorescence intensity (an
excitation wavelength 488 nm, an emission wavelength 525 nm) of dichloro-
ﬂuorescein by Inﬁnite M200 microplate reader (Tecan Japan Co., Kanagawa,
Japan). The results of intracellular ROS are expressed in arbitrary units.
mtDNA content. Well-conserved nuclear and other mitochondrial genes were
selected to quantify mtDNA copy number per nuclear genome. Cytochrome c
oxidase subunit 2 was used as a marker for mtDNA and uncoupling protein 2
for nuclear DNA. Renal DNA was extracted from frozen kidney tissues of all
animals using the DNeasy tissue kit. Total DNA concentration was determined
using a PicoGreen DNA quantitation kit. Speciﬁc mouse primer sequences are
provided in the Supplementary Table 1. mtDNA per nuclear genome was calcu-
lated as the ratio of cytochrome c oxidase subunit 2 DNA to uncoupling protein 2
DNA (30) and expressed as the fold increase relative to that found in db/m mice.
Citrate synthase activity. Citrate synthase activity in the kidney was de-
termined using the citrate synthase activity measurement kit, according to the
manufacturer’s instructions.
Electron microscopy. The mitochondria in proximal tubular cells were ob-
served by electron microscopy as previously described (23). Mitochondrial
area and number were estimated in 15–18 micrographs, which were taken for
renal proximal tubular cells of three animals of each group (20). The mito-
chondrial area was measured using the ImageJ software, and the number of
mitochondria per cell was counted manually by a blind observer.
Statistical analysis. Data are expressed as means 6 SD. The Tukey multiple-
comparison test was used to determine the signiﬁcance of pairwise differ-
ences among three or more groups. P , 0.05 was considered signiﬁcant.
FIG. 1. Treatment with RSV ameliorates the mesangial matrix expansion in db/db mice. A: Representative photomicrographs of PAS-stained kidney
(a–d). Data are results of independent experiments in each group with six mice per group. Original magniﬁcation: 3400. Treatment with RSV
reduced glomerular and interstitial ﬁbronectin accumulation and the number of F4/80-positive cells in db/db mice. Representative photomicro-
graphs of immunohistochemistry for glomerular ﬁbronectin (e–h), interstitial ﬁbronectin (i–l), and F4/80 (m–p). Data are the results of in-
dependent experiments in each group with three to ﬁve mice per group. Original magniﬁcation, 3400 for glomerular ﬁbronectin, 3200 for
interstitial ﬁbronectin, and 3100 for F4/80 staining. B: Quantitative assessment of the mesangial matrix area. Data are means 6 SD (n =6 ,# P <
0.01 vs. other groups). C–E: Quantitative assessment of ﬁbronectin and F4/80 staining. Data are means 6 SD (n =3 –5, #P < 0.01 vs. other groups).
(A high-quality digital representation of this ﬁgure is available in the online issue.)
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Characteristics of experimental mice. Table 1 details
the characteristics of four groups of mice at the end of the
experimental period. The whole body and right kidney
weights were signiﬁcantly higher in db/db mice compared
with db/m mice. The mean blood pressure (MBP) was
signiﬁcantly higher in db/db mice than in db/m mice. RSV
did not affect changes in MBP. db/db mice exhibited
markedly elevated blood glucose levels compared with db/m
mice throughout the entire experiment. In db/db mice,
treatment with RSV induced a partial improvement in
blood glucose levels and glycated hemoglobin by the end
of the experiments. Serum lipid proﬁles including total
cholesterol, triglyceride, and free fatty acid levels were
also signiﬁcantly elevated in db/db mice compared with
db/m mice; the increases in triglycerides and free fatty acids
were partially rescued by RSV (Table 1). In addition, an
impairment of glucose and insulin tolerance was evident in
db/db mice relative to db/m mice (Supplementary Fig. 1),
and high levels of fasting glucose and insulin (Table 1)
indicating insulin resistance were also observed in db/db
mice. Such alteration of insulin resistance in db/db mice was
partially improved by treatment with RSV. There were no
differences in body weight and food consumption between
FIG. 2. RSV suppresses oxidative damage in db/db mice, and RSV scavenges O
22 production from mitochondria. A: Urinary 8-OHdG excretion for
24 h was measured. Data are means 6 SD (n =9 –11, #P < 0.05 vs. other groups). B: 8-OHdG contents in mtDNA of the kidney samples were measured.
Data are means 6 SD (n =3 –4, #P < 0.05 vs. db/m mice group). C: Frequencies of deletion mutation of mtDNA in the kidney were determined by
quantitative PCR method. Data are means 6 SD (n =3 –4, #P < 0.05 vs. other groups). D:O
22 production from renal isolated mitochondria by
stimulation with succinate and antimycin A was determined in all groups. O
22 production was expressed as counts of CL per 100 mg protein. Data
are means 6 SD (n =8 ,# P < 0.05 vs. db/m mice group). E:O
22 production in mitochondria isolated from the kidneys of db/db mice by stimulation
with succinate and antimycin A was measured in RSV at various concentrations (10
23–100 mmol/L) or SOD (100 U/mL). O
22 production was
expressed as counts of CL per 100 mg protein. Data are means 6 SD (n =8 ,# P < 0.01 vs. control [0]). F:O
22 production from the reaction of
hypoxanthine/xanthine oxidase was measured in RSV at various concentrations (10
23–100 mmol/L) or SOD (100 U/mL). The inhibitory effect of
RSV against O
22 on this reaction was expressed as % counts of CL. Data are means 6 SD (n =4 ,# P < 0.01 vs. control [0]).
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volume was signiﬁcantly larger in db/db mice compared
with db/m mice, and this was partially reduced by treat-
ment with RSV (data not shown).
Changes in urinary albumin excretion. To evaluate the
effects of RSV on functional abnormalities in db/db mice,
we measured the urinary albumin excretion. Values were
markedly higher in db/db mice and RSV treatment signiﬁ-
cantly reduced urinary albumin excretion (Table 1), in-
dicating that RSV ameliorates the functional abnormality
of diabetic nephropathy in db/db mice.
Changes in kidney morphology. Figure 1A a–d shows
representative photomicrographs of mesangial matrix ac-
cumulation in the PAS-stained kidneys of the four groups.
The mesangial matrix was more extensive in the glomeruli
of db/db mice than in db/m mice, and treatment with RSV
reduced such expansion. Figure 1B shows the results of
quantitative analysis of mesangial matrix expansion in all
groups. Although the ratio of mesangial matrix/glomerular
area was markedly larger in db/db mice than in db/m mice,
treatment with RSV signiﬁcantly reduced this expansion.
Immunohistochemistry for ﬁbronectin (Fig. 1A e–h and
i–l) also showed a signiﬁcantly higher score for renal glo-
merular and tubulointerstitial expression in db/db mice
than in db/m mice (Fig. 1C and D). Treatment with RSV
reduced the score for ﬁbronectin in db/db mice but had no
effect on db/m (Fig. 1C and D).
The number of cells positive for F4/80 (a macrophage
marker) in the renal interstitial lesion was signiﬁcantly
higher in db/db mice than in db/m mice (Fig. 1A m–p), but
this pattern was not found in the glomeruli (data not shown).
Treatment with RSV reduced the number of F4/80-positive
cells in the renal interstitial lesions of db/db mice (Fig. 1E).
These results indicate that RSV might improve glomerular
and interstitial histological abnormalities including mesan-
gial expansion, ﬁbronectin accumulation and increased in-
terstitial macrophage inﬁltration in the kidney of db/db mice.
Changes in urinary 8-OHdG excretion and mitochon-
drial oxidative damage in the kidney. Urinary 8-OHdG
excretion was markedly higher in db/db mice compared
with db/m mice but diminished after treatment with RSV
(Fig. 2A). The 8-OHdG content (Fig. 2B) and subsequent
deletion mutation (Fig. 2C) in the mtDNA isolated from the
kidneys of db/db mice were signiﬁcantly higher than in
db/m mice. These mitochondrial alterations in mtDNA were
not observed in the kidney of db/db mice treated with RSV.
In addition, O
22 production from the isolated renal mito-
chondria after stimulation with succinate and antimycin A
was signiﬁcantly increased in db/db mice, but treatment
with RSV restored it to normal in db/db mice. In ex vivo
experiments, the addition of RSV exogenously attenuated
the levels of O
22 from the renal mitochondria of db/db
mice in a dose-dependent manner (Fig. 2D). Moreover,
RSV could also scavenge O
22 production from reaction of
hypoxanthine and xanthine oxidase in a dose-dependent
manner. These results suggest that the enhancement of
both systemic oxidative damage and renal mitochondrial
oxidative damage was observed in db/db mice and that
RSV has antioxidative activity.
Changes in nitrotyrosine expression in the kidney.
Figure 3A a–h show representative immunohistochemical
staining for nitrotyrosine in the kidney. The semiquantitative
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FIG. 3. Treatment with RSV suppresses diabetes-induced nitrotyrosine staining in the mouse kidney. A: Representative photomicrographs of renal
nitrotyrosine expression. Data are results of independent experiments in each group with six mice per group. Original magniﬁcation: 3400 for
glomerular nitrotyrosine (a–d) and 3100 for tubulointerstitial nitrotyrosine (e–h) staining. B and C: Semiquantitative scores for nitrotyrosine in
glomerular and tubulointerstitial lesions. Data are means 6 SD (n =6 ,# P < 0.05 vs. other groups). (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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tubulointerstitial lesions of the renal cortex were in-
creased in db/db mice compared with those of db/m mice
(Fig. 3B and C). Treatment with RSV reduced the scores in
the glomeruli and tubulointerstitium of db/db mice but had
no effect on the lesions of db/m mice (Fig. 3B and C).
These results indicate that tyrosine nitration of proteins is
enhanced in the kidney of db/db mice and that RSV seems
to attenuate the effect.
Changes in Mn-SOD expression and activity in the
kidney. The mRNA and protein expression of Mn-SOD
was higher in db/db mice than in db/m mice (Fig. 4A–C).
The Mn-SOD activity was signiﬁcantly lower in the kidney
of db/db mice compared with that of db/m mice (Fig. 4D).
Nitrotyrosine immunoreactivity was signiﬁcantly higher in
Mn-SOD immunoprecipitates from the kidney of db/db
mice than in that from db/m mice, and the increase in
immunoreactivity was attenuated by treatment with RSV in
db/db but not db/m mice (Fig. 4E and F). These ﬁndings
suggest that Mn-SOD activity could be reduced by modi-
fying tyrosine nitration in the kidneys of db/db mice.
mRNA levels of mitochondrial biogenesis–related
genes and the enzyme activity of citrate synthase.
To evaluate mitochondrial biogenesis, we assessed peroxi-
some proliferator-activated receptor g coactivator (PGC)-
1a, nuclear respiratory factor (NRF)-1, and cytochrome
c oxidoreductase mRNA expression levels and mtDNA
contents in the kidney. The citrate synthase activity was
also measured in the kidney. All these were signiﬁcantly
higher in the kidneys of db/db mice than in that of db/m
mice (Fig. 5A–E). These changes improved following
treatment with RSV, consistent with the observed normali-
zation of Mn-SOD activity and oxidative stress.
Electron microscopy. To conﬁrm the beneﬁcial effects of
RSV on mitochondrial biogenesis, we examined the renal
morphology in more detail by electron microscopy. The
number and area of the mitochondria were signiﬁcantly
larger in renal proximal tubular cells of db/db mice com-
pared with db/m mice, but treatment with RSV rescued
these differences in db/db mice (Fig. 6A–C).
Changes in AMPK activation and SIRT 1 expression
in the kidney. We assessed whether RSV activates AMPK
in the kidney using immunoblotting for phosphorylation of
AMPK. Activation of AMPK was signiﬁcantly reduced in
the kidney of db/db mice compared with db/m mice, and
RSV did not alter AMPK activation in the kidney (Fig. 7A
and B). In addition, SIRT1 expression was no different
among the groups (Fig. 7A and C).
RSV exerts antioxidative effects in AMPK/SIRT1-
independent mechanism in cultured renal proximal
tubular cells. RSV attenuated intracellular ROS in both
the SIRT1-knocked-down and DN-AMPK–overexpressing
FIG. 4. Mn-SOD expression and activity in the kidney. A: Mn-SOD mRNA expression in kidneys was quantiﬁed by real-time PCR and expressed as
fold increase relative to db/m mice. Data are means 6 SD (n =9 –11, #P < 0.05 vs. other groups). B: Mn-SOD protein expression in the kidney shown
by representative immunoblots of Mn-SOD in protein extracts from the kidneys of mice of each group. Actin was loaded as an internal control. C:
Quantitative analysis of Mn-SOD protein expression in the kidneys. Data are means 6 SD (n =4 ,# P < 0.05 vs. other groups). D: Mn-SOD activity in
the kidney homogenate is expressed as fold increase compared with db/m mice. Data are means 6 SD (n =9 –11, #P < 0.05 vs. other groups).
Immunoreactivity to nitrotyrosine for immunoprecipitated Mn-SOD. Proteins from the kidneys of each group were immunoprecipitated with anti–
Mn-SOD antibodies and blotted for nitrotyrosine antibodies. Representative results of Western blotting are shown (E), and the ratio to immu-
noprecipitated Mn-SOD is shown (F). Data are means 6 SD (n = 6, #P < 0.05 vs. other groups).
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These results indicate that RSV exerts antioxidative ef-
fects independent of the AMPK/SIRT1 pathway (Fig. 7D
and E).
DISCUSSION
In this study, we showed the potential beneﬁts of RSV in
ameliorating the renal injury and the enhanced mito-
chondrial biogenesis with Mn-SOD dysfunction observed
in the diabetic kidney. We also demonstrated that RSV
seems to exert these effects by improving the oxidative
stress status in the kidney via the scavenging of ROS,
normalization of Mn-SOD dysfunction, and partial rescue
of glucose-lipid metabolism. Also, such antioxidative effects
of RSV could be exerted in an AMPK/SIRT1-independent
mechanism.
First, we showed that RSV improved renal functional
and histological abnormalities such as albuminuria,
mesangial expansion, glomerular and interstitial ﬁbronec-
tin accumulation, and interstitial macrophage inﬁltration in
the kidney of db/db mice, a type 2 diabetes animal model.
Oxidative stress has been implicated in the pathogenesis
of diabetic nephropathy, and high glucose-induced ROS
in renal mesangial or tubular cells contribute to over-
production of extracellular matrix proteins and inﬂam-
mation (31,32). Because it has been reported that RSV is
a robust scavenger of ROS (6,7), we assessed whether RSV
has beneﬁcial effects against diabetes-induced systemic
and renal oxidative stress by measuring urinary 8-OHdG
excretion and renal immunostaining for nitrotyrosine.
Moreover, not only are mitochondria an important source
of ROS, but also they themselves can be damaged by ROS.
Therefore, we also assessed renal mitochondrial oxidative
stress by measuring accumulation of mitochondrial 8-
OHdG and D-17 deletion of mtDNA, which have been ob-
served in diabetic nephropathy (33) and aging (24). In the
current study, renal nitrotyrosine expression and mito-
chondrial oxidative damage indicated systemic, renal and
particularly mitochondrial enhanced oxidative stress in the
kidney of db/db mice, and there was clear attenuation of
these markers following treatment with RSV. In addition,
we showed that isolated mitochondrial O
22 production by
stimulation with succinate and antimycin A was increased
in db/db mice, and the RSV could scavenge ROS from the
mitochondria.
The mitochondria are an important source of ROS in
diabetes (9), and ROS metabolism in the mitochondria is
mainly regulated by Mn-SOD, which is an important anti-
oxidative enzyme in the mitochondria. In the diabetic
state, high glucose- or FFA-induced overproduction of
ROS from the mitochondria is inhibited by overexpression
of Mn-SOD in vascular cells and tissues (9,34–37). More-
over, heterozygous Mn-SOD deﬁcient mouse, which only
have 50% of the Mn-SOD activity seen in wild-type mice,
showed O
22-induced mitochondrial oxidative damage (38),
together with massive glomerulosclerosis, tubulointerstitial
damage and inﬂammation including macrophage inﬁltration
in the kidney (39). Therefore, regulation of ROS metabolism
FIG. 5. PGC-1a, NRF-1, and cytochrome c oxidoreductase mRNA expression levels, mtDNA contents, and the enzyme activity of citrate synthase in
the kidney. The mRNA expression levels of PGC-1a (A), NRF-1 (B), cytochrome c oxidoreductase (C), and mtDNA contents (D) were quantiﬁed by
real-time PCR and expressed as fold increases from db/m mice. Data are means 6 SD (n =9 –11, mRNA expression, n =6 –8; mtDNA content, #P <
0.05 vs. other groups, ##P < 0.01 vs. other groups). E: The citrate synthase activity was measured in the kidney of all groups. Data are means 6 SD
(n =8 ,# P < 0.05 vs. other groups).
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protective factor in managing diabetic vascular compli-
cations including nephropathy. It is also known that ty-
rosine nitration at the active site of Mn-SOD is associated
with reduction in enzymatic activity in the kidneys of
several disease models (26,40–42). In the current study,
we showed reduced Mn-SOD activity even when the ex-
pression of Mn-SOD was increased, and the former was
probably caused by increased tyrosine nitration in the
kidney of db/db mice. RSV might reduce tyrosine nitration
of Mn-SOD and rescue the activation, resulting in im-
provement of mitochondrial oxidative stress and renal
injury in diabetic kidney. Thus, RSV might ameliorate
systemic, renal, and particularly mitochondrial oxidative
stress in diabetes via the direct scavenging of ROS and
normalization of the Mn-SOD function.
It has been reported recently that reduced mitochon-
drial biogenesis in insulin resistant tissues such as skeletal
muscle, liver, or fat is associated with the pathogenesis of
type 2 diabetes (11). In addition to its function as a ROS
scavenger, several reports have implicated RSV in acti-
vating the AMPK/SIRT1 pathway to induce mitochondrial
biogenesis (14), leading to life span prolongation and im-
provement of high-fat diet–induced metabolic impairment
such as obesity and insulin resistance (12,13). We therefore
examined mitochondrial biogenesis in the kidney based on
mtDNA contents, mitochondria area and number, citrate
synthase activity and overexpression of PGC-1a, NRF-1,
cytochrome c oxidoreductase, and Mn-SOD. Interestingly,
these factors were all enhanced in the kidney of db/db
mice compared with db/m mice, and were rescued by RSV
treatment, consistent with attenuation of systemic and
renal mitochondrial oxidative stress including tyrosine
nitration of Mn-SOD. Moreover, RSV did not alter AMPK
activation or induction of Mn-SOD expression in the kid-
ney. We also showed that RSV attenuated intracellular
ROS in both the SIRT1 knocked-down and the DN-AMPK–
overexpressing renal proximal tubular cells. These results
suggest that systemic and/or renal mitochondrial oxidative
stress contributes to the enhanced mitochondrial bio-
genesis in the kidney of the db/db mice and that RSV might
improve mitochondrial biogenesis through the attenuation
of oxidative stress, rather than through the activation of
the AMPK/SIRT1 pathway. In this regard, Shen et al. (20)
demonstrated that oxidative stress–induced mitochondrial
biogenesis was increased in the myocardium of OVE26
diabetic mice as a possible compensatory reaction against
oxidative stress–induced mitochondrial damage. More-
over, they showed that the myocardium-speciﬁc Mn-SOD
transgenic mice crossed with OVE26 diabetic mice showed
FIG. 6. Electron microscopy of kidney. A: Representative micrographs of proximal tubular cells from mice treated with RSV. Scale bar = 2 mm.
Quantitative assessment of number (B) and area (C) of mitochondria in proximal tubular cells in mice treated with RSV. Data are means 6 SD
(n =3 ,# P < 0.01 vs. other groups).
M. KITADA AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, FEBRUARY 2011 641improvement of oxidant-induced mitochondrial biogenesis
and dysfunction (37). Therefore, we suggest that the en-
hanced mitochondrial biogenesis in the kidney of db/db
mice might also be a compensatory response to oxidative
stress–induced mitochondrial damage; however further
study is needed to elucidate the role of enhanced mito-
chondrial biogenesis associated with Mn-SOD dysfunction.
RSV has also been shown to reduce elevated blood
glucose levels and metabolic impairment in diabetes, to be
associated with mitochondrial biogenesis through the
AMPK/SIRT1 activation pathway, as discussed above
(12,13,43). In the current study, the elevated levels of glu-
cose, glycated hemoglobin, triglycerides, and free fatty
acids and impairment of glucose/insulin tolerance in db/db
mice improved to some extent by treatment with RSV. It is
therefore possible that RSV acts as an enhancer of mito-
chondrial biogenesis through AMPK/SIRT1 activation in
liver and skeletal muscle, resulting in demonstrated im-
provements in abnormal glucose-lipid metabolism in db/db
mice. In fact, we found that the phosphorylation of AMPK
was reduced in the liver of db/db mice, and RSV could re-
store its alteration (data not shown). Therefore, RSV is likely
exerting some of its effects via improvement of glucose
homeostasis, and the systemic improvement of metabolism
might at least in part contribute to the amelioration of renal
oxidative stress and renal injury.
In conclusion, our study indicated that the enhanced
mitochondrial biogenesis with Mn-SOD dysfunction by tyro-
sine nitration was observed in the diabetic kidney. RSV seems
to improve these functional and histological abnormalities
and ameliorate the enhanced mitochondrial biogenesis
in diabetic kidney, possibly by attenuating the oxidative
stress through scavenging of the ROS, by the normalization
of the Mn-SOD dysfunction in an AMPK/SIRT1-independent
mechanism, and by the partial improvement of the glucose
and lipid metabolism.
ACKNOWLEDGMENTS
This work was supported by a Grant-in-Aid for Scientiﬁc
Research (21591148) to D.K., and the grant from the
Uehara Memorial Foundation to D.K.
No potential conﬂicts of interest relevant to this article
were reported.
M.K. collected and analyzed the data and wrote the
manuscript. S.K. collected and analyzed the data and
contributed to discussion. N.I. collected and analyzed the
data. D.K. contributed to discussion and reviewed and
edited the manuscript.
The authors thank Yuki Tanaka and Eiko Kobori for the
technical support on ﬁbronectin immunohistochemistry
and maintenance of animals and collecting their physio-
logical data. The authors also thank Dr. Issa F.G., Word-
Medex Pty Ltd. for help with preparing the manuscript.
REFERENCES
1. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of
resveratrol. Cardiovasc Drug Rev 2004;22:169–188
2. Do Amaral CL, Francescato HD, Coimbra TM, et al. Resveratrol attenuates
cisplatin-induced nephrotoxicity in rats. Arch Toxicol 2008;82:363–370
FIG. 7. AMPK activation and SIRT1 expression in the kidney and RSV attenuates ROS in both the SIRT1-knocked-down and the DN-AMPK–
overexpressing renal mProx. A: Representative immunoblots of phospho-AMPKa (Thr172), AMPKa, and SIRT1 in protein extracts from the
kidneys of mice of each group. Actin was loaded as an internal control. B: Quantitative analysis of phospho-AMPKa (Thr172). C: Quantitative
analysis of SIRT1 protein expression. Data are means 6 SD (n =4 ,# P < 0.05 vs. db/m mice and db/m mice treated with RSV). D: Effects of RSV on
the attenuation of oxidative stress in both the pSUPERretro and pSUPERretro-SIRT1 infected mProx exposed to H2O2. Data are means 6 SD (n =
3, #P < 0.05 vs. other groups). E: Effects of RSV on the attenuation of oxidative stress in the adenovirus including GFP or DN-AMPK–over-
expressing mProx exposed to H2O2. Data are means 6 SD (n =3 ,# P < 0.05 vs. other groups).
RESVERATROL IMPROVES TYPE 2 DIABETIC NEPHROPATHY
642 DIABETES, VOL. 60, FEBRUARY 2011 diabetes.diabetesjournals.org3. Nihei T, Miura Y, Yagasaki K. Inhibitory effect of resveratrol on pro-
teinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci
2001;68:2845–2852
4. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a poly-
phenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharma-
cology 2006;76:69–75
5. Sener G, Tu gtepe H, Yüksel M, Cetinel S, Gedik N, Ye gen BC. Resveratrol
improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch
Med Res 2006;37:822–829
6. Leonard SS, Xia C, Jiang BH, et al. Resveratrol scavenges reactive oxygen
species and effects radical-induced cellular responses. Biochem Biophys
Res Commun 2003;309:1017–1026
7. Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional ac-
tivity. Antioxid Redox Signal 2009;11:2851–2897
8. Ceriello A. New insights on oxidative stress and diabetic complications
may lead to a “causal” antioxidant therapy. Diabetes Care 2003;26:1589–
1596
9. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial su-
peroxide production blocks three pathways of hyperglycaemic damage.
Nature 2000;404:787–790
10. MacMillan-Crow LA, Thompson JA. Tyrosine modiﬁcations and in-
activation of active site manganese superoxide dismutase mutant (Y34F)
by peroxynitrite. Arch Biochem Biophys 1999;366:82–88
11. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin
resistance. Circ Res 2008;102:401–414
12. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and
survival of mice on a high-calorie diet. Nature 2006;444:337–342
13. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mi-
tochondrial function and protects against metabolic disease by activating
SIRT1 and PGC-1alpha. Cell 2006;127:1109–1122
14. Um JH, Park SJ, Kang H, et al. AMP-activated protein kinase-deﬁcient mice
are resistant to the metabolic effects of resveratrol. Diabetes 2010;59:554–
563
15. Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endo-
crinol 2009;5:367–373
16. Perez-de-Arce K, Foncea R, Leighton F. Reactive oxygen species mediates
homocysteine-induced mitochondrial biogenesis in human endothelial
cells: modulation by antioxidants. Biochem Biophys Res Commun 2005;
338:1103–1109
17. Suematsu N, Tsutsui H, Wen J, et al. Oxidative stress mediates tumor
necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction
in cardiac myocytes. Circulation 2003;107:1418–1423
18. Liu CS, Tsai CS, Kuo CL, et al. Oxidative stress-related alteration of the
copy number of mitochondrial DNA in human leukocytes. Free Radic Res
2003;37:1307–1317
19. Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy
gene expression in tissues of mitochondrial disease patients. J Biol Chem
1999;274:22968–22976
20. Shen X, Zheng S, Thongboonkerd V, et al. Cardiac mitochondrial damage
and biogenesis in a chronic model of type 1 diabetes. Am J Physiol En-
docrinol Metab 2004;287:E896–E905
21. Koya D, Haneda M, Nakagawa H, et al. Amelioration of accelerated di-
abetic mesangial expansion by treatment with a PKC beta inhibitor in di-
abetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000;14:
439–447
22. Deji N, Kume S, Araki S, et al. Structural and functional changes in the
kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol
2009;296:F118–F126
23. Kume S, Uzu T, Horiike K, et al. Calorie restriction enhances cell adap-
tation to hypoxia through Sirt1-dependent mitochondrial autophagy in
mouse aged kidney. J Clin Invest 2010;120:1043–1055
24. Kakoki M, Kizer CM, Yi X, et al. Senescence-associated phenotypes in
Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.
J Clin Invest 2006;116:1302–1309
25. Daiber A, Oelze M, August M, et al. Detection of superoxide and perox-
ynitrite in model systems and mitochondria by the luminol analogue L-012.
Free Radic Res 2004;38:259–269
26. Guo W, Adachi T, Matsui R, et al. Quantitative assessment of tyrosine ni-
tration of manganese superoxide dismutase in angiotensin II-infused rat
kidney. Am J Physiol Heart Circ Physiol 2003;285:H1396–H1403
27. Takaya K, Koya D, Isono M, et al. Involvement of ERK pathway in albumin-
induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol
Renal Physiol 2003;284:F1037–F1045
28. Kume S, Haneda M, Kanasaki K, et al. SIRT1 inhibits transforming growth
factor beta-induced apoptosis in glomerular mesangial cells via Smad7
deacetylation. J Biol Chem 2007;282:151–158
29. Kim SY, Jeoung NH, Oh CJ, et al. Activation of NAD(P)H:quinone oxido-
reductase 1 prevents arterial restenosis by suppressing vascular smooth
muscle cell proliferation. Circ Res 2009;104:842–850
30. Civitarese AE, Ukropcova B, Carling S, et al. Role of adiponectin in human
skeletal muscle bioenergetics. Cell Metab 2006;4:75–87
31. Ha H, Lee HB. Reactive oxygen species as glucose signaling molecules in
mesangial cells cultured under high glucose. Kidney Int Suppl 2000;77:S19–
S25
32. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcamí J, et al. Hydrogen peroxide
increases extracellular matrix mRNA through TGF-beta in human me-
sangial cells. Kidney Int 2001;59:87–95
33. Kakimoto M, Inoguchi T, Sonta T, et al. Accumulation of 8-hydroxy-29-
deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic
rats. Diabetes 2002;51:1588–1595
34. Kiritoshi S, Nishikawa T, Sonoda K, et al. Reactive oxygen species from
mitochondria induce cyclooxygenase-2 gene expression in human me-
sangial cells: potential role in diabetic nephropathy. Diabetes 2003;52:
2570–2577
35. Munusamy S, MacMillan-Crow LA. Mitochondrial superoxide plays a cru-
cial role in the development of mitochondrial dysfunction during high
glucose exposure in rat renal proximal tubular cells. Free Radic Biol Med
2009;46:1149–1157
36. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase
in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci
2006;47:1594–1599
37. Shen X, Zheng S, Metreveli NS, Epstein PN. Protection of cardiac mito-
chondria by overexpression of MnSOD reduces diabetic cardiomyopathy.
Diabetes 2006;55:798–805
38. Williams MD, Van Remmen H, Conrad CC, Huang TT, Epstein CJ,
Richardson A. Increased oxidative damage is correlated to altered mito-
chondrial function in heterozygous manganese superoxide dismutase
knockout mice. J Biol Chem 1998;273:28510–28515
39. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, Vaziri ND.
Association of mitochondrial SOD deﬁciency with salt-sensitive hyper-
tension and accelerated renal senescence. J Appl Physiol 2007;102:255–260
40. van der Loo B, Labugger R, Skepper JN, et al. Enhanced peroxynitrite for-
mation is associated with vascular aging. J Exp Med 2000;192:1731–1744
41. Cruthirds DL, Novak L, Akhi KM, Sanders PW, Thompson JA, MacMillan-
Crow LA. Mitochondrial targets of oxidative stress during renal ischemia/
reperfusion. Arch Biochem Biophys 2003;412:27–33
42. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Ni-
tration and inactivation of manganese superoxide dismutase in chronic
rejection of human renal allografts. Proc Natl Acad Sci USA 1996;93:
11853–11858
43. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as
therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712–716
M. KITADA AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, FEBRUARY 2011 643